Pharmaceutical Drug Delivery Market

Pharmaceutical Drug Delivery Market worth $2,546.0 billion by 2029

The report "Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029", is projected to reach USD 2,546.0  billion by 2029 from USD 1,949.4 billion in 2024 at  a CAGR of  5.5% during the forecast period.

Browse 907 market data Tables and 63 Figures spread through 718 Pages and in-depth TOC on "Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html

Globally, the growing burden of chronic diseases like diabetes, hypertention, rising aging population  globally are anticipated to accelerate the demand for drug delivery, further propelling the adoption of pharmaceutical drug delivery products . Moreover, the growing focus on patient convenience and government initiative to aid affordibility and accessibility are likely to fuel the market growth. Moreover, the increasing investments for new product development and growing  adoption of home care settings and self administration owing to its advantages are expecetd to support  the pharmaceutical drug delivery market growth during the forecast period.

Risk of needlestick injuries associated with drug delivery products and high cost of development , reducing the affordibiity of drug delivery products amoung patients and healthcare providers are likely to hamper the growth of pharmaceutical drug delivery market

The injectable drug delivery segment, is expected to register the largest market share of the global pharmaceutical drug delivery market  in 2023.

The pharmaceutical drug delivery market is segmented based on route of administration. Among route of administration segments, the injectable drug delivery  segment held the largest market share and anticipated to grow at a significant pace during forecast period. Owing to increasing prevalence of chronic disease as injectables are used in many therapeutic areas. The injectable route is also a promising alternative for drug delivery over oral route .It also enhances patient compliance and reduce the frequency of dosage administration. Due to growing preference in self-administration and home care, there has been significant development in injectables with a focus to minimize needle complications and pain. These factors are boosting the growth of injectable drug delivery at higher  rate.

The hospital segment, is predicted to capture the largest market share of the global pharmaceutical drug delivery market  in 2023.

The pharmaceutical drug delivery market is classified into hospitals, ambulatory surgical centers/clinics, diagnostic centers, home care settings, and other settings based on facility of use. The hospital segment is predicted to grow at a significant pace owing to the increasing number of inpatient and outpatient visits in hospitals and the requirement of large volumes of drugs and their respective delivery devices. Additionally, the increase in number of surgeries being performed and rising prevalence of chronic diseases across the globe leads to higher hospital admissions and, in turn, boost the pharmaceutical drug delivery market in this segment.

“The North America market, by region, to register highest growth rate in the forecast period.”

On the basis of region, the pharmaceutical drug delivery market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa.  The North America market is likely to witness significant market growth. This is attribute to the rise in geriatric patient population, increasing cases of chronic diseases, moreover improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility drug delivery products. The geographical expanion and presence of key players in the region are likely to support  growth of pharmaceutical drug delivery market in North America.

As of 2023, pharmaceutical drug delivery in was dominated by Johnson & Johnson services, inc (US) , Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US) , Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Sanofi (France), Bayer AG (Germany), among others

Don’t miss out on business opportunities in Pharmaceutical Drug Delivery Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]

Pharmaceutical Drug Delivery Market Size,  Share & Growth Report
Report Code
MD 3871
PR Published ON
9/17/2024
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Drug Delivery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
...

Digital Virtual Assistant - MarketsandMarkets

Home